ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Approves BMS’s Yervoy For Metastatic Melanoma

March 25, 2011

In Brief: USC Study Finds Sedentary Occupations Increase Colon Cancer Risk for Men Over More Active Jobs

November 30, 1984

NHGRI’s ENCODE project to identify all genome parts.

October 10, 2003

CCOP Application Now Total 180 Plus

November 26, 1982

Home Test Detects Hematuria Earlier

August 4, 1989

NCAB Subcommittee Urges New Centers Categories, Recognition Of More New Comprehensive Centers

March 28, 1975